ICLR

Icon Plc

167.17

Aug 12 • 3:59 PM ET +1.59 (0.96%)

167.17

Aftermarket • 7:34 PM ET 0.00 (0.00%)

Healthcare Diagnostics & Research Ireland Large NASD

Peers: IQV CRL MEDP LH DGX TMO A DHR WAT BIO

| Held by: DFSV PIEQ DFAT SPDW TSME DSTL DFAC VT BASV FNDX

Scroll to Statements

Index	-
Market Cap	12.90B
Enterprise Value	15.50B
Income	42.34M
Sales	8.29B
Book/sh	121.55
Cash/sh	12.03
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	40100
IPO	May 15, 1998

P/E	303.45
Forward P/E	14.01
PEG	5.29
P/S	1.56
P/B	1.38
P/C	13.89
P/FCF	14.43
EV/EBITDA	12.43
EV/Sales	1.87
Quick Ratio	0.95
Current Ratio	0.95
Debt/Eq	0.38
LT Debt/Eq	0.24
Option/Short	Yes / Yes

EPS (ttm)	0.55
EPS next Y	11.93
EPS next Q	2.68
EPS this Y	-15.43%
EPS next Y	12.63%
EPS next 5Y	2.65%
EPS past 3/5Y	-22.33% -14.31%
Sales past 3/5Y	2.15% 24.15%
EPS Y/Y TTM	-94.18%
Sales Y/Y TTM	2.08%
EPS Q/Q	-63.33%
Sales Q/Q	1.20%
Earnings	Jul 29 AMC
EPS/Sales Surpr.	0.57% 2.95%

Insider Own	0.93%
Insider Trans	-1.43%
Inst Own	105.21%
Inst Trans	0.58%
ROA	0.26%
ROE	0.45%
ROIC	0.37%
Gross Margin	19.45%
Oper. Margin	10.14%
Profit Margin	0.51%
SMA20	0.23%
SMA50	3.71%
SMA200	13.52%
Trades

Shs Outstand	77.15M
Shs Float	76.43M
Short Float	2.91%
Short Ratio	2.26
Short Interest	2.22M
52W High	203.91 -18.02%
52W Low	66.57 151.12%
Volatility	3.63% 4.37%
ATR (14)	7.55
RSI (14)	53.36
Beta	1.20
Rel Volume	0.84
Avg Volume	984.58K
Volume	822,285

Perf Week	2.24%
Perf Month	-0.48%
Perf Quarter	37.09%
Perf Half Y	15.65%
Perf YTD	-8.26%
Perf Year	-1.13%
Perf 3Y	-35.30%
Perf 5Y	-30.00%
Perf 10Y	118.27%
Recom	1.95
Target Price	187.60
Prev Close	165.58
Price	167.17
Change %	0.96%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-30-26	Upgrade	Truist	Hold → Buy	$207
Jun-25-26	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$185
May-18-26	Resumed	RBC Capital Mkts	Sector Perform	$123
Mar-26-26	Upgrade	BMO Capital Markets	Market Perform → Outperform	$130
Feb-23-26	Upgrade	Jefferies	Hold → Buy	$135
Feb-18-26	Upgrade	TD Cowen	Hold → Buy	$120
Feb-17-26	Downgrade	Rothschild & Co Redburn	Buy → Neutral	$100
Feb-12-26	Downgrade	Leerink Partners	Outperform → Market Perform	$105
Feb-12-26	Downgrade	BofA Securities	Neutral → Underperform	$75
Jan-08-26	Downgrade	Truist	Buy → Hold	$222
Dec-15-25	Downgrade	BofA Securities	Buy → Neutral	$195
Nov-13-25	Initiated	BMO Capital Markets	Market Perform	$175
Sep-09-25	Downgrade	Jefferies	Buy → Hold	$175
Sep-03-25	Upgrade	Rothschild & Co Redburn	Neutral → Buy	$236
Aug-21-25	Downgrade	Citigroup	Buy → Neutral	$200
Jul-24-25	Upgrade	Robert W. Baird	Neutral → Outperform	$224
Apr-29-25	Downgrade	JP Morgan	Overweight → Neutral	$150
Apr-14-25	Downgrade	TD Cowen	Buy → Hold	$157
Apr-10-25	Downgrade	Barclays	Overweight → Equal Weight	$165
Mar-21-25	Downgrade	Goldman	Buy → Neutral	$250 → $200

Show Previous Ratings

Aug-06-26 06:30AM	ICON Announces Pricing of USD 2.15 Billion Notes (Business Wire)
Aug-04-26 08:39AM	ICON Announces Private Offering of Notes (Business Wire)
Jul-31-26 04:15PM	ICON Announces Results of Annual General Meeting (Business Wire)
Jul-30-26 03:03PM	Icon PLC (ICLR) (Q2 2026) Earnings Call Highlights: Strong Bookings Surge Amid Margin Pressures (GuruFocus.com) -7.10%
Jul-29-26 04:15PM	ICON Reports Second Quarter 2026 Results (Business Wire)
10:04AM	Loading…
Jul-28-26 10:04AM	ICON Announces Multi-Year Anthropic Collaboration to Expand AI Across Clinical Trials (InvestorsHub) +6.79%
07:00AM	ICON announces multi-year collaboration with Anthropic to bring frontier AI to clinical trials (Business Wire)
Jul-22-26 06:00AM	ICON Schedules Second Quarter 2026 Earnings Conference Call (Business Wire)
Jun-24-26 03:00PM	Icon PLC (ICLR) Q1 2026 Earnings Call Highlights: Strong Bookings and Strategic Expansions Amid ... (GuruFocus.com) +10.86%
Jun-23-26 04:15PM	ICON Reports First Quarter 2026 Results (Business Wire)
Jun-22-26 07:00AM	ICON selects Microsoft as a preferred technology partner to power AI-enabled clinical development (Business Wire)
Jun-17-26 04:15PM	ICON Schedules First Quarter 2026 Earnings Conference Call (Business Wire)
May-29-26 08:30AM	ICON Public Limited Company Q4 2025 Earnings Call Summary (Moby)
May-28-26 07:02PM	Icon PLC (ICLR) Q4 2025 Earnings Call Highlights: Strong Bookings Amid Revenue Challenges (GuruFocus.com) +15.49%
May-18-26 09:55AM	Zscaler upgraded, CoreWeave downgraded: Wall Street's top analyst calls (The Fly)
08:00AM	Loading…
May-13-26 08:00AM	ICON expands US early phase research capabilities with new clinic and outpatient centres (Business Wire)
Mar-26-26 09:45AM	Spotify initiated, Qualcomm downgraded: Wall Street's top analyst calls (The Fly)
Mar-24-26 08:00AM	ICON and Advarra Introduce New 'Research-Ready,' Connected Site Network Model (Business Wire)
Mar-11-26 06:00AM	Icon price target lowered to $120 from $200 at Citi (TipRanks)
Mar-10-26 09:11AM	Polen Global Growth Strategy Sold ICON plc (ICLR) Due to Short-Term Growth Challenges (Insider Monkey)
Mar-09-26 12:17AM	Lost Money on ICON Public Limited Company (ICLR)? Possible Fraud - Contact Levi & Korsinsky Today (Newsfile)
Mar-05-26 09:56AM	Jefferies Upgrades ICON Public Limited Company (ICLR) to Buy from Hold (Insider Monkey)
Mar-02-26 12:55AM	Lost Money on ICON Public Limited Company (ICLR)? Possible Fraud - Contact Levi & Korsinsky Today (Newsfile)
Mar-01-26 04:23AM	Jefferies Bullish on ICON (ICLR) Despite Share Price Decline (Insider Monkey)
Feb-26-26 06:45PM	Progyny (PGNY) Q4 Earnings and Revenues Surpass Estimates (Zacks) +5.08%
Feb-24-26 02:46PM	Here is Why ICON Public Limited Company (ICLR) Offers an Impressive Upside (Insider Monkey)
Feb-23-26 09:08PM	Analyst Report: ICON Public Limited Company (Morningstar Research)
Feb-18-26 10:10AM	FDA Grants Breakthrough Status To Johnson & Johnson's Cancer Drug For Advanced Head and Neck Cancer (Benzinga) +8.89%
Feb-17-26 09:43AM	Dollar General downgraded, Dollar Tree upgraded: Wall Street's top analyst calls (The Fly)
Feb-15-26 08:32AM	Clinical Research Provider Icon Stock Crashes On Accounting Probe (Benzinga)
08:17AM	Loading…
Feb-14-26 08:17AM	ICON Public Limited Company (ICLR) Delays Earnings Amid Internal Investigation (Insider Monkey)
Feb-13-26 11:25PM	ICON PLC (ICON) Soars 16% as Analyst Issues 'Hold', $93 PT Despite Accounting Concerns (Insider Monkey) +16.13%
Feb-12-26 04:16PM	Icon Plummets As Accounting Investigation Threatens 2025 Earnings (Investor's Business Daily) -39.85%
02:19PM	ICON Shares Plunge 50% After Revenue Overstatement Disclosure (GuruFocus.com)
11:10AM	Why this drug-research company's stock is having its worst day since 1999 (MarketWatch)
10:07AM	Stocks Mixed on Strength in Chipmakers and Weakness in Cisco Systems (Barchart)
09:44AM	Shopify upgraded, Coinbase downgraded: Wall Street's top analyst calls (The Fly)
07:38AM	Clinical Research Provider Icon Stock Crashes On Accounting Probe (Benzinga)
Feb-11-26 10:00AM	Analysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out for (Zacks) -7.89%
Feb-05-26 07:23PM	Analyst Report: ICON Public Limited Company (Morningstar Research) -10.86%
Jan-27-26 07:15AM	ICON's Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership (Business Wire)
Jan-22-26 12:06AM	ICON PLC (ICLR) Trades Below Normal Earnings Despite Strong Fundamentals (Insider Monkey)
Jan-05-26 07:27AM	Artisan Mid Cap Value Fund Increased its Stake in ICON Public Limited Company (ICLR). Here's Why (Insider Monkey)
Dec-17-25 08:53AM	Here's Why ICON Plc. (ICLR) Gained +20.3% in Q3 (Insider Monkey)
Dec-10-25 10:31AM	BMO Capital Maintains Outlook On ICON Public Limited Company (ICLR) After Management Call (Insider Monkey)
Dec-09-25 07:46AM	Here's How ICON plc (ICLR) Recovered from Challenges (Insider Monkey)
07:15AM	ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive (Business Wire)
Dec-02-25 07:15AM	ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions (Business Wire)
Nov-27-25 11:30AM	Labcorp (LH) Up 8.1% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-26-25 06:27PM	Analyst Report: ICON Public Limited Company (Morningstar Research) +5.23%
Nov-25-25 07:46AM	Tempus AI's Data Business Is Expanding and Adding to Revenues: Here's How (Zacks) +6.07%
Nov-21-25 11:30AM	Icon PLC (ICLR) Down 12.2% Since Last Earnings Report: Can It Rebound? (Zacks)
Nov-13-25 09:11AM	ICON Public Limited Company (ICLR) Soared on Robust Performance (Insider Monkey)
Nov-12-25 06:45AM	ICON plc to Present at the Jefferies London Healthcare Conference (Business Wire)
Nov-06-25 07:28PM	Analyst Report: ICON Public Limited Company (Morningstar Research)
Oct-24-25 06:41PM	Analyst Report: ICON Public Limited Company (Morningstar Research)
Oct-23-25 11:15AM	Medpace Holdings' Good Quarter Is Another Sign Biotech Is Back (Barrons.com) -6.54%
Oct-22-25 05:45PM	Icon PLC (ICLR) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
04:25PM	ICON Reports Third Quarter 2025 Results (Business Wire)
Oct-20-25 10:00AM	Analysts Estimate Revvity (RVTY) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-15-25 10:00AM	Analysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-01-25 06:48PM	Analyst Report: ICON Public Limited Company (Morningstar Research) +9.89%
Sep-26-25 08:52AM	ICON Public Limited Company (ICLR) Fell Due to Weak Results and an Uncertain Outlook (Insider Monkey)
Sep-14-25 01:17AM	Jefferies Downgrades ICON Public Limited (ICLR) to Hold From Buy (Insider Monkey)
Sep-09-25 12:11PM	Jefferies backs IQVIA and Charles River, cuts ICON on customer losses (Investing.com)
Sep-04-25 08:00AM	ICON Announces CEO Transition (Business Wire)
Sep-02-25 06:00AM	ICON plc to Participate at Upcoming Investor Conferences (Business Wire)
Sep-01-25 12:20PM	3 Healthcare Pathbreakers With Long-Term Tailwinds (MarketBeat)
Aug-18-25 06:45PM	Analyst Report: ICON Public Limited Company (Morningstar Research)
Aug-12-25 11:41PM	Mizuho Raises PT on ICON Public Limited Company (ICLR) to $225; Maintains 'Outperform' Rating (Insider Monkey) +5.87%
08:54AM	ICON (ICLR) Fell Along with Broader CROs (Insider Monkey)
Aug-11-25 07:50AM	ICON plc (ICLR) Fell due to Persistent Volatility in the Clinical Development Market (Insider Monkey)
Aug-06-25 06:42PM	Analyst Report: ICON Public Limited Company (Morningstar Research) -6.36%
Jul-25-25 09:45PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Jul-24-25 06:37PM	Analyst Report: ICON Public Limited Company (Morningstar Research) +16.15%
Jul-23-25 05:50PM	Icon PLC (ICLR) Q2 Earnings and Revenues Top Estimates (Zacks)
04:20PM	ICON Announces Results of Annual General Meeting (Business Wire)
04:15PM	ICON Reports Second Quarter 2025 Results (Business Wire)
Jul-17-25 10:00AM	Labcorp Holdings (LH) Earnings Expected to Grow: Should You Buy? (Zacks)
Jul-16-25 10:00AM	Analysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out for (Zacks)
07:15AM	ICON's Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report (Business Wire)
Jul-15-25 09:32AM	Do You Believe in the Upside Potential of ICON PLC (ICLR)? (Insider Monkey)
Jul-07-25 07:15AM	ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability (Business Wire)
07:06AM	Clearbridge Large Cap Growth Strategy Sold Its Stake in ICON Public Limited Company (ICLR) (Insider Monkey)
Jul-03-25 10:13AM	Will ICON PLC (ICLR) Benefit from R&D Spending? (Insider Monkey)
Jun-27-25 09:15AM	Tempus AI's Data Business Keeps Scaling Up: Can the Growth Pace Last? (Zacks)
Jun-23-25 06:30AM	ICON plc Schedules Second Quarter 2025 Earnings Conference Call (Business Wire)
Jun-02-25 10:23AM	Here's Why You Should Retain ICLR Stock in Your Portfolio Now (Zacks)
04:12AM	ICLR Shareholders Have the Right to Lead the ICON Public Limited Company Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ICLR (PR Newswire)
May-30-25 11:31AM	Icon PLC (ICLR) Down 9.7% Since Last Earnings Report: Can It Rebound? (Zacks)
May-27-25 08:30AM	ICON plc to Present at the William Blair 45th Annual Growth Stock Conference (Business Wire)
May-19-25 04:15PM	ICON releases its ICON Cares 2024 Report (Business Wire)
May-14-25 07:52AM	ICON Public Limited Company (ICLR): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying (Insider Monkey) -5.88%
May-09-25 03:13AM	ICON Public Limited Company (ICLR): Among Steven Cohen's Mid-Cap Stock Picks with Huge Upside Potential (Insider Monkey)
May-07-25 12:55PM	ICON Public Limited Company (ICLR): A Bull Case Theory (Insider Monkey)
07:27AM	Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies (Business Wire)
May-02-25 09:00PM	LRT Capital Management April 2025 Investor Update (Seeking Alpha)
03:01AM	Icon PLC (ICLR) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Initiatives (GuruFocus.com)
02:42AM	ICON Public Limited Company (ICLR) Q1 2025 Earnings Call Transcript (Seeking Alpha)
May-01-25 06:43PM	Analyst Report: ICON Public Limited Company (Morningstar Research)

ICON plc engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. The firm specializes in the development, management, and analysis of programs that support clinical development. It operates through the following geographical segments: Ireland, Rest of Europe, U.S., and Rest of World. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.

CEO & DirectorMr. Barry Balfe

Founder & Independent Non-Executive DirectorDr. John Climax Ph.D.

Chief Financial OfficerMr. Nigel Clerkin A.C.A.

Chief Commercial OfficerMr. Steve Empoliti

Chief Accounting OfficerLyons Emer

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Whitaker Anne Clem	Director	Aug 11 '26	Sale	164.29	841	138,168	891	Aug 12 05:02 PM
O'Neill Julie	Director	Aug 11 '26	Sale	164.29	915	150,326	3,515	Aug 12 05:01 PM
Murray Ciaran	Director	Aug 11 '26	Sale	164.29	2,677	439,803	20,452	Aug 12 05:00 PM
Murphy Ronan Martin	Director	Aug 11 '26	Sale	164.29	841	138,168	3,847	Aug 12 05:00 PM
McCague Eugene Pacelli	Director	Aug 11 '26	Sale	164.29	841	138,168	3,811	Aug 12 04:59 PM
Grais Linda	Director	Aug 11 '26	Sale	164.29	841	138,169	6,162	Aug 12 04:47 PM
CLIMAX JOHN DR	Director	Aug 11 '26	Sale	164.29	841	138,168	2,087	Aug 12 04:47 PM
Clerkin Nigel Bernard John	Chief Financial Officer	Aug 11 '26	Sale	164.29	2,267	372,445	5,881	Aug 12 04:46 PM
ANNE WHITAKER	Director	Aug 11 '26	Proposed Sale	164.29	841	138,170		Aug 11 05:12 PM
LINDA SUE GRAIS	Director	Aug 11 '26	Proposed Sale	164.29	841	138,170		Aug 11 05:10 PM
EUGENE PACELLI MCCAGUE	Director	Aug 11 '26	Proposed Sale	164.29	841	138,170		Aug 11 05:09 PM
JOHN CLIMAX	Director	Aug 11 '26	Proposed Sale	164.29	841	138,170		Aug 11 05:06 PM
RONAN MARTIN MURPHY	Director	Aug 11 '26	Proposed Sale	164.29	841	138,170		Aug 11 05:04 PM
JULIE ANN O'NEILL	Director	Aug 11 '26	Proposed Sale	164.29	915	150,327		Aug 11 05:02 PM
NIGEL CLERKIN	Officer	Aug 11 '26	Proposed Sale	164.29	2,267	372,451		Aug 11 05:00 PM
CIARAN MURRAY	Director	Aug 11 '26	Proposed Sale	164.29	2,677	439,810		Aug 11 04:58 PM
Balfe Barry Edward	Chief Executive Officer	Aug 10 '26	Sale	164.07	382	62,676	4,804	Aug 11 04:22 PM
BARRY EDWARD BALFE	Officer	Aug 10 '26	Proposed Sale	164.07	382	62,676		Aug 10 04:02 PM
BARRY EDWARD BALFE	Officer	Mar 09 '26	Proposed Sale	105.13	2,862	300,875		Mar 09 05:14 PM
BARRY EDWARD BALFE	Officer	Mar 04 '26	Proposed Sale	109.25	566	61,837		Mar 04 04:07 PM
NIGEL CLERKIN	Officer	Nov 03 '25	Proposed Sale	169.24	1,473	249,289		Nov 03 04:23 PM
STEPHEN CUTLER	Officer	Oct 02 '25	Proposed Sale	190.19	18,901	3,594,781		Oct 02 04:03 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ICLR

Icon Plc

Upgrade your Finviz experience